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Background: Seasonal variations in cardiovascular disease is well recognized. However, little is known
about the presentations and outcomes of Japanese heart failure (HF) patients in the winter season.
Methods and results: We used a single hospital-based cohort from the Shinken Database 2004–2012,
comprising all new patients (n=19,994) who visited the Cardiovascular Institute Hospital. A total of 375
patients who were admitted owing to acute decompensated HF were included in the analysis. Of these
patients, 136 (36%) were admitted in winter. Winter was deﬁned as the period between December and
February. The HF patients admitted in winter were older, and had a higher prevalence of hypertension
and diabetes mellitus than the patients admitted in other seasons. Patients with conditions categorized
as clinical scenario 1 tended to be admittedmore commonly inwinter. HFwith preserved left ventricular
ejection fraction (LVEF) was more common in HF patients admitted in winter than in those admitted in
other seasons. Beta-blocker use at hospital dischargewasmore common in the patients admitted in other
seasons. Kaplan–Meier curves and log-rank test results indicated that the incidences of all-cause death,
cardiovascular death, and HF admission were comparable between the patients admitted in winter and
those admitted in other seasons.
Conclusions: HF admission was frequently observed in the winter season and HF patients admitted in the
winter season were older, and had higher prevalence of hypertension and diabetes mellitus, and pre-
served LVEF suggesting that wemight need to paymore attention for elderly patients with hypertension,
diabetes mellitus, and HF with preserved LVEF to decrease HF admissions in the winter season.
© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.ntroduction
The seasonal variation in the incidence of various cardiovascular
iseases is well established [1–4]. The environmental tempera-
ure is associated with this variability, as cardiovascular events
eak in winter. The physiologic consequences of a cold climate
re thought to result in increased coronary risk factors and might
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iovascular Institute, 3-2-19, Nishiazabu, Minato-ku, Tokyo 106-0031, Japan.
el.: +81 3 3408 2151; fax: +81 3 3408 2159.
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ttp://dx.doi.org/10.1016/j.jjcc.2014.03.004
914-5087/© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights realso cause clinical deterioration in patients with heart failure (HF).
Skin cooling has been shown to increase systemic vascular resis-
tance [5], heart rate [6], plasma norepinephrine concentration [7],
circulating levels of vasoconstrictor peptides [8], and blood pres-
sure (BP) [9]. In keeping with these changes, BP is higher in winter
[10]. Cold can also induce myocardial ischemia [11]. All of these
effects could clearly lead to worsening of HF. However, little is
known about the clinical characteristics and outcomes of Japanese
HF patients admitted in winter. In the present study, we aimed to
elucidate the characteristics and clinical outcomes of patients with
acute decompensated HF admitted in winter by examining data
fromourhospital-based cohort selected from the ShinkenDatabase
2004–2012.
served.
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tudy patients
The Shinken Database includes all patients who visited the
ardiovascular Institute in Tokyo, Japan (“Shinken” is a Japanese
bbreviation for the name of the hospital), and excludes patients
ho are foreign travelers and those with active cancer. This
ospital-based database was established to investigate the preva-
ence and prognosis of cardiovascular diseases in the urban areas
f Japan [12,13]. The registry began in June 2004, and patients
ave been continually registered to the database annually. The
resent study analyzed data from this database collected between
une 2004 and March 2013 (Shinken Database 2004–2012) and
ncluded 19,994 new visiting patients. Among them, 537 patients
ere admitted to our institute due to acute decompensatedHF.We
xcluded HF patients with primary valvular heart disease (n=138)
nd acute coronary syndrome (n=24). Valvular heart disease
as deﬁned as long-standing mitral or aortic valve involvement,
s documented by physical examination and echocardiography,
ngiography, or history of surgical repair. Finally, 375patientswere
xamined in the present study (Fig. 1). These patients were fol-
owed up for an average period of 857±846 days. Winter was
eﬁned as the period between December and February.
thics
The ethical committee of the Cardiovascular Institute approved
his study, and all the patients provided written informed consent.
ata collection
For each patient, after undergoing electrocardiography and
hest radiography, cardiovascular statuswas evaluated by echocar-
iography, an exercise test, 24-h Holter recordings, and blood
aboratory data, as prescribed by the attending physician, within 3
onths after the ﬁrst visit. As initial clinical parameters, collected
ata included gender, age, body mass index, drug information, and
oexisting conditions, including hypertension, atrial ﬁbrillation,
iabetes mellitus, and dyslipidemia. In most patients, additional
chocardiographic parameters included left ventricular diameter
f the diastole (LVDd), LV diameter of the systole (LVDs), interven-
ricular septum thickness (IVST), posterior wall thickness (PWT),
nd LV ejection fraction (LVEF) using M-mode echocardiography.
nemia was deﬁned as a hemoglobin level of <11g/dL. An esti-
ated glomerular ﬁltration rate (eGFR) was calculated using the
GFR equation for the Japanese population: eGFR=194× (serum
The Shinken Database 2004-2012
(n=19,994)
Acute Decompensated Heart Failure Admission
(n=537)
Examined in the Present Study
(n=375)
Primary Valvular Disease
(n=138)
Acute Coronary Syndrome
(n=24)
Fig. 1. Patient ﬂow chart of the present study.iology 64 (2014) 470–475 471
creatinine)−1.094 × (age)−0.287 × (0.739, if the patient is female)
[14]. A baseline eGFR<60mLmin−1 1.73m−2 was used to deﬁne
chronic kidney disease (CKD) [15]. Idiopathic dilated cardiomy-
opathy was diagnosed by the presence of global LV dilatation
with impaired systolic function occurring in the absence of known
cardiac causes. Hypertrophic cardiomyopathy was diagnosed by
echocardiographywhen hypertrophy (IVST or PWT>12mm)with-
out hypertension was present. We deﬁned HFpEF patients as HF
patients with preserved LVEF (i.e. LVEF>50%), and HFrEF patients
as HF patients with reduced LVEF (i.e. LVEF≤50%), as previously
described [16,17]. Patients were divided into three groups by clin-
ical scenario (CS): CS1, systolic BP (SBP) at admission >140mmHg;
CS2, ≥100mmHg; CS3, <100mmHg [18]. We conﬁrmed the deaths
of study patients by the medical records of our hospital or by the
information obtained during follow-up.We deﬁned cardiovascular
death as death resulting from acute myocardial infarction, sudden
cardiac death, death due to heart failure, death due to stroke, or
death due to other cardiovascular causes [19]. We conﬁrmed HF
events (HF requiring hospitalization or death due to HF) that were
classiﬁed as per the International Classiﬁcation of Diseases, 10th
revision, code I50, using the medical records of our hospital or by
the information obtained from follow-up.
Patient follow-up
The health status, incidence of cardiovascular events and mor-
tality of patients are maintained in the database by linking these
data to the medical records of the hospital and through study doc-
uments that were sent one a year to those who stopped hospital
visits or who were referred to other hospitals.
We excluded the follow-up data obtained after April 1, 2013
from data analysis. Therefore, the end of the follow-up period was
deﬁned as one of the following: (1) the date of death, if the date
was before March 31, 2013; (2) the ﬁnal hospital visit or the ﬁnal
response to our study documents involving prognosis with conﬁr-
mation of being alive before March 31, 2013; (3) March 31, 2013,
when the date of death, the ﬁnal hospital visit, or the ﬁnal response
to our study documents involving prognosis was later than April 1,
2013.
Statistical analysis
Categorical and consecutive data regarding patient background
are presented as numbers (%) and means± standard deviation,
respectively. The chi-square test was used for comparisons
between groups, and the unpaired t-test was used for compari-
son of consecutive variables. Long-term, event-free survival was
estimated using Kaplan–Meier curves and the log-rank test to
assess the signiﬁcance of differences between the two groups.
Logistic regression analysis was used to identify the determinants
of HF patients in the winter season. Univariate and age-adjusted
Cox regression analysis were performed to clarify the association
between HF admission in the winter season and long-term clinical
outcomes. A probability value of <0.05 was considered to indi-
cate a statistically signiﬁcant difference. Statistical analyses were
performed using SPSS (SPSS Inc., Chicago, IL, USA), version 19.0
software.
Results
Patient characteristicsAmong the 375 patients with HF, 136 (36%) were admit-
ted in winter, and 239 patients (64%) were admitted in the
other seasons. The distribution of the admission month among
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the HF patients admitted in winter, and in 10% (0.8%) of those
admitted in the other seasons. Cardiovascular death occurred in
6.6% of the patients in winter, and 7.5% of patients in the other
seasons. Readmission for HF occurred in 25% of the patients
Table 1
Characteristics of patients.
Other seasons
(n=239)
Winter season
(n=136)
p-Value
Age (years) 67±14 70±13 0.034
Male 72% 68% 0.412
BMI (kg/m2) 24±4.6 25±4.3 0.295
Hypertension 54% 65% 0.025
Dyslipidemia 28% 37% 0.079
Diabetes mellitus 24% 35% 0.023
Hyperuricemia 23% 24% 0.909
Cigarette smoking 39% 43% 0.397
CKD 13% 16% 0.460
Anemia 21% 18% 0.390
ICM 30% 28% 0.655
DCM 23% 16% 0.099
HCM 2.5% 4.4% 0.315
HHD 4.6% 8.8% 0.101
AF 36% 40% 0.474
WBC (/L) 7570±2925 7857±3408 0.394
CRP (mg/dL) 1.7±3.4 1.9±4.2 0.578
BNP (pg/mL) 874±902 859±874 0.877
CS
I 29% 39% 0.051
II 63% 55% 0.111
III 7% 6% 0.705Fig. 2. Distribution of mo
he study patients is shown in Fig. 2. The HF patients admit-
ed in the winter season were older than those admitted in the
ther seasons (70±13 years vs. 67±14 years, p=0.034). Gen-
er difference was not seen between the two groups. Patients
f winter season had a higher prevalence of hypertension (65%
s. 54%, p=0.025) and diabetes mellitus (35% vs. 24%, p=0.023).
he prevalence rates of ischemic cardiomyopathy, dilated car-
iomyopathy, hypertrophic cardiomyopathy, and hypertensive
eart disease were comparable between the two groups. White
lood cell counts (7570±2925L vs. 7857±3408L, p=0.394)
nd C-reactive protein levels (1.7±3.4mg/dL vs. 1.9±4.2mg/dL,
= 0.578) at admission were comparable between the patients
n winter and other seasons. B-type natriuretic peptide levels at
dmission were also comparable between the patients in winter
ndother seasons (859±874pg/mLvs. 874±902pg/mL,p=0.877).
heconditionclassiﬁedasCS1 tended tobemorecommon inwinter
dmission group (39% vs. 29%, p=0.051) (Table 1).
ltrasound cardiography
Ultrasound echocardiography revealed that LVDd (53±10mm
s. 56±11mm, p=0.014), and LVDs (41±14mm vs. 45±14mm,
=0.013) were smaller in HF patients in winter than those in other
easons. LVEF was greater in HF patients in the winter season
47±21% vs. 39±20%, p=0.001). The prevalence of HFpEF was
igher in HF patients in the winter season (46% vs. 30%, p=0.002)
Table 2).
edication at hospital discharge
The use of beta-blockers was more common in the HF patients
dmitted in the other seasons than in those admitted inwinter (71%
s. 60%, p=0.032). The use of other cardiovascular drugs including
alcium channel blockers, rennin-angiotensin-system inhibitors,
tatins, loop diuretics, aldosterone antagonists, digitalis, nitrate,
ndamiodaronewascomparablebetween the twogroups (Table3).eterminants of heart failure in winter
Multivariate logistic regression analysis (step-wise model)
ncluding following covariates age ≥75 years, hypertension,th
mong the study patients.
diabetes mellitus, and HFpEF demonstrated that diabetes mellitus
[odds ratio (OR) 1.698, 95% conﬁdence interval (CI) 1.064–2.708,
p=0.026] andHFpEF (OR 1.969, 95% CI 1.264–3.067, p=0.003)were
independent determinants of HF admission in winter (Table 4).
Clinical outcomes
All-cause death (in-hospital death) occurred in 9.6% (1.5%) ofBMI, body mass index; CKD, chronic kidney disease; ICM, ischemic cardiomyopa-
thy; DCM, idiopathic dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy;
HHD, hypertensive heart disease; AF, atrial ﬁbrillation;WBC,white blood cell count;
CRP, C-reactive protein level; BNP, brain natriuretic peptide; CS, clinical scenario.
Data are expressed as mean± standard deviation, or percentage.
H. Kaneko et al. / Journal of Card
Table 2
Ultrasound cardiography ﬁndings.
Other seasons
(n=239)
Winter season
(n=136)
p-Value
IVST (mm) 9.8±4.6 10.1±2.7 0.533
PWT (mm) 9.0±1.9 9.2±2.0 0.258
LVDd (mm) 56±11 53±10 0.014
LVDs (mm) 45±14 41±14 0.013
LVEF (%) 39±20 47±21 0.001
HFpEF 30% 46% 0.002
HFrEF 70% 55% 0.002
LAD (mm) 44±9.5 44±9.2 0.480
IVST, interventricular septum thickness; PWT, posterior wall thickness; LVDd, left
ventricular end-diastolic dimension; LVDs, left ventricular end-systolic dimension;
LVEF, left ventricular ejection fraction; HFpEF, heart failure with preserved left ven-
tricular ejection fraction; HFrEF, heart failure with reduced left ventricular ejection
fraction; LAD, left atrial dimension. Data are expressed as mean± standard devia-
tion.
Table 3
Medication at hospital discharge.
Other seasons
(n=237)
Winter season
(n=134)
p-Value
Beta-blockers 71 60 0.032
CCBs 30 36 0.212
RAS-Is 75 72 0.566
Statins 30 32 0.608
Loop diuretics 77 81 0.306
Aldosterone antagonist 47 38 0.102
Digitalis 16 15 0.778
Nitrate 12 7 0.115
Amiodarone 7.6 4.5 0.241
CCB, calcium-channel blocker; RAS-I, renin-angiotensin system inhibitor. Data are
expressed as percentages.
Table 4
Determinants of winter heart failure.
OR 95% CI p-Value
Diabetes mellitus 1.698 1.064–2.708 0.026
HFpEF 1.969 1.264–3.067 0.003
Logistic regression analysis for heart failure admission in winter. OR, odds ratio;
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DI, conﬁdence interval; HFpEF, heart failure with preserved left ventricular ejection
raction.
dmitted in winter and 22% of the patients in the other seasons
Table 5). Kaplan–Meier curves and log-rank test showed that
he incidences of all-cause death (Fig. 3A, log-rank p=0.950), car-
iovascular death (Fig. 3B, log-rank p=0.826), and HF admission
Fig. 3C, log-rank p=0.314) of the patients admitted in winter
nd the other seasons. Similar to Kaplan–Meier curves, unadjusted
ox regression analysis demonstrated that HF admission in win-
er was not signiﬁcantly associated with all-cause death (HR 0.979,
5% CI 0.498–1.923, p=0.950), cardiovascular disease death (HR
.914, 95% CI 0.411–2.036, p=0.826), and heart failure admission
HR 1.247, 95% CI 0.810–1.919, p=0.315). Even after adjustment
or age, HF admission in winter was not signiﬁcantly associated
ith all-cause death (HR 0.923, 95% CI 0.470–1.815, p=0.817),
able 5
linical outcomes.
Other seasons
(n=239)
Winter season
(n=136)
p-Value
All-cause death 10 9.6 0.880
In-hospital death 0.8 1.5 0.566
Cardiovascular death 7.5 6.6 0.742
Heart failure admission 22 25 0.533
ata are expressed as percentages.iology 64 (2014) 470–475 473
cardiovascular death (HR 0.860, 95% CI 0.386–1.916, p=0.712), and
HF admission (HR 1.216, 95% CI 0.790–1.871, p=0.375) (Supple-
mentary Table 1).
Discussion
The present study reports the data from an observational cohort
of HF patients that was analyzed to determine the characteris-
tics and outcomes of acute decompensated HF patients who were
admitted in winter. The major ﬁndings of the present study were
as follows:
(1) Admission for HF occurred frequently inwinter (136/375, 36%).
(2) The HF patients admitted in the winter season were older than
those admitted in the other seasons. The prevalence of hyper-
tension and diabetes mellitus was greater in the patients in the
winter season. The CS1 classiﬁcation tended to be more com-
mon and LVEF was higher in the patients admitted in winter
than in those admitted in other seasons.
(3) Kaplan–Meier curves and log-rank test results showed the inci-
dences of all-cause death (log-rank p=0.950), cardiovascular
death (log-rank p=0.826), and hospital admission for HF (log-
rank p=0.314) in the patients admitted in winter and other
seasons.
In the present study, HF admission was commonly observed in
winter (36%) when comparedwith the other seasons, whichwas in
agreement with a previous study [20]. HF patients admitted in the
winter seasonwere older than those admitted in the other seasons.
Furthermore, patients in the winter season more frequently had
hypertension and diabetes mellitus compared with those admit-
ted in the other seasons. Interestingly, HF patients in winter had a
higher prevalence of HFpEF than HF patients in the other seasons.
As older age, hypertension, and diabetes mellitus are well-known
clinical features of HFwith preserved LVEF [17], our results suggest
that HFpEF is an important clinical presentation of HF patients in
the winter season.
Despite these differences in patient characteristics, clinical
outcomes including in-hospital mortality, long-term mortality,
long-term cardiovascular mortality, and occurrences of re-
admission for HF were comparable between the HF patients
admitted in winter and the other seasons. Since HF patients in
winter were older than those admitted in the other seasons, we
performed an age-adjusted Cox regression analysis. Even after
adjustment for age, HF admission in winter was not signiﬁcantly
associated with long-term outcomes. Because the HF patients
admitted in winter had diabetes mellitus more frequently, we
might expect these patients to have worse clinical outcomes than
those admitted in the other seasons. On the other hand, thepatients
admitted inwinterweremore likely to have a CS1 condition, which
was thought tobeassociatedwith clinical outcomesmore favorable
than other CS categories.
The results of the present study are in keeping with the sea-
sonal variation observed in other cardiovascular diseases such as
acute coronary syndrome and sudden death [1,4]. Consequently,
these cardiovascular diseases might share common mechanisms
that exacerbate the amplitude of the seasonal variation of other
cardiovascular syndromes. For example, thehemodynamic stresses
and neurohumoral activation that accompany lower temperatures
might exacerbate HF, induce myocardial ischemia, and precipitate
arrhythmias [6–11]. Furthermore, both ischemia and arrhyth-
mias could worsen HF. Other mechanisms could also underlie
the seasonal variation in HF. For example, respiratory infection,
especially those related to inﬂuenza, are more frequent in winter
and could precipitate HF [21]. Although there were no signiﬁcant
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wFig. 3. Kaplan–Meier curves for all-cause death rate (A), ca
ifferences in the white blood cell counts and serum C-reactive
rotein levels on hospital admission between patients in winter
nd other seasons, we need to pay attention to infections includ-
ng respiratory infection and inﬂuenza virus infection as important
orsening factors of HF in the winter season. In addition, alcoholascular death rate (B), and heart failure admission rate (C).
consumption increases in December [22]. Considering that alcohol
induces atrial ﬁbrillation and depresses myocardial contractility,
increased consumption of alcohol might aggravate HF in winter
[22,23].Depression,whichalsoworsens in thewinter season,might
contribute to acute HF [24].
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The results of the present study have clinical signiﬁcance and
ight affect HF management. Considering that almost 40% of the
F admissions in this study occurred in winter, increased vigilance
n winter is warranted in clinical practice. Moreover based on the
igher prevalence of older age, hypertension, and CS1 in the HF
atients seen in winter, BP control should be closely monitored in
uch patients, especially among the elderly.
tudy limitations
The present study had several limitations. Our hospital is a
ingle-department cardiovascular facility; therefore, the results of
his study cannot be generalized to all medical centers. Further-
ore, the sample sizeof thepresent studywas limited, and thus, the
tatistical power might not be strong enough for any negative data
o be conclusive. As described above, the inﬂammatorymarkers on
dmissionwere comparable betweenHFpatients in thewinter sea-
on and in the other seasons. However, further studies are needed
o clarify the association between infection and HF admission in
he winter season.
onclusions
HF admissionwas frequently observed in thewinter season and
F patients admitted in the winter season were older, had higher
revalence of hypertension and diabetes mellitus, and preserved
VEF. Therefore, we might need to pay more attention to elderly
atients with hypertension, diabetes mellitus, and HF with pre-
erved LVEF to decrease HF admissions in the winter season.
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